KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 113 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,175,934 | +2.4% | 1,056,691 | -4.3% | 0.02% | +4.5% |
| Q2 2023 | $9,939,051 | +18.8% | 1,104,339 | +3.8% | 0.02% | +15.8% |
| Q1 2023 | $8,365,705 | +16.3% | 1,064,339 | 0.0% | 0.02% | +11.8% |
| Q4 2022 | $7,194,932 | -54.1% | 1,064,339 | -1.4% | 0.02% | -56.4% |
| Q3 2022 | $15,661,000 | +44.1% | 1,079,339 | -2.3% | 0.04% | +56.0% |
| Q2 2022 | $10,867,000 | -18.5% | 1,104,339 | +22.1% | 0.02% | 0.0% |
| Q1 2022 | $13,330,000 | +13.9% | 904,339 | +2.3% | 0.02% | +19.0% |
| Q4 2021 | $11,700,000 | -24.2% | 884,339 | 0.0% | 0.02% | -30.0% |
| Q3 2021 | $15,432,000 | -27.2% | 884,339 | -0.1% | 0.03% | -28.6% |
| Q2 2021 | $21,205,000 | +2.5% | 885,000 | +9.9% | 0.04% | 0.0% |
| Q1 2021 | $20,680,000 | +263.0% | 805,000 | +168.3% | 0.04% | +250.0% |
| Q4 2020 | $5,697,000 | +13.1% | 300,000 | -25.0% | 0.01% | -7.7% |
| Q3 2020 | $5,036,000 | +4.0% | 400,000 | 0.0% | 0.01% | +8.3% |
| Q2 2020 | $4,840,000 | +58.2% | 400,000 | 0.0% | 0.01% | +33.3% |
| Q1 2020 | $3,060,000 | -65.6% | 400,000 | -20.0% | 0.01% | -59.1% |
| Q4 2019 | $8,905,000 | +9.7% | 500,000 | -28.6% | 0.02% | +10.0% |
| Q3 2019 | $8,120,000 | -47.6% | 700,000 | 0.0% | 0.02% | -48.7% |
| Q2 2019 | $15,505,000 | -18.5% | 700,000 | +5.3% | 0.04% | -18.8% |
| Q1 2019 | $19,032,000 | +60.6% | 665,000 | +10.8% | 0.05% | +45.5% |
| Q4 2018 | $11,850,000 | +75.6% | 600,000 | +96.6% | 0.03% | +120.0% |
| Q3 2018 | $6,748,000 | – | 305,187 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |